According to 10x Genomics 's latest financial reports the company's total assets are $0.96 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.96 B | -6.2% |
2022-12-31 | $1.02 B | 1% |
2021-12-31 | $1.01 B | 9.63% |
2020-12-31 | $0.92 B | 53.38% |
2019-12-31 | $0.60 B | 387.43% |
2018-12-31 | $0.12 B | 64.41% |
2017-12-31 | $75.6 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Organovo ONVO | $8.88 M | -99.08% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $0.20 B | -79.04% | ๐ฌ๐ง UK |
Novavax NVAX | $1.79 B | 86.24% | ๐บ๐ธ USA |
Novocure
NVCR | $1.14 B | 18.75% | Jersey |